Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient
ASH 2019 AML Update: Maintenance Therapy is Likely to Become Standard - Update on Trials with Oral Azacitidine & Gilteritinib
Comments 1
Login to view comments.
Click here to Login